6008 Federal Register / Vol. 81, No. 23 / Thursday, February 4, 2016 / Notices 

toll-free, dial-in number at 1–866–659– 

0537 and the pass code is 9933701. 

Background: The Advisory Board on 

Radiation and Worker Health (ABRWH 

or the Advisory Board) was established 

under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that 

have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule; advice on 

methods of dose reconstruction, which 

have also been promulgated by HHS as 

a final rule; advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program; and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort. 

In December 2000, the President 

delegated responsibility for funding, 

staffing, and operating the Advisory 

Board to HHS, which subsequently 

delegated this authority to CDC. 

National Institute for Occupational 

Safety and Health (NIOSH) implements 

this responsibility for CDC. The charter 

was issued on August 3, 2001, renewed 

at appropriate intervals, and will expire 

on August 3, 2017. 

Purpose: The Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at 

any Department of Energy facility who 

were exposed to radiation but for whom 

it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. SPR 

was established to aid the Advisory 

Board in carrying out its duty to advise 

the Secretary, HHS, on dose 

reconstruction. SPR is responsible for 

overseeing, tracking, and participating 

in the reviews of all procedures used in 

the dose reconstruction process by the 

NIOSH Division of Compensation 

Analysis and Support (DCAS) and its 

dose reconstruction contractor (Oak 

Ridge Associated Universities—ORAU). 

Matters for Discussion: The agenda for 

the Subcommittee meeting includes 

discussion of procedures in the 

following ORAU and DCAS technical 

documents: OCAS Technical 

Information Bulletin (TIB) 0014 (‘‘Rocky 

Flats Internal Dosimetry Coworker 

Extension’’), ORAU OTIB 0013 

(‘‘Individual Dose Adjustment 

Procedures for Y–12 Dose 

Reconstructions’’), ORAU OTIB 0029 

(‘‘Internal Dose Reconstructions for Y– 

12’’), ORAU OTIB 0039 (‘‘Internal Dose 

Reconstructions for Hanford’’), ORAU 

OTIB 0050 (‘‘The Use of Rocky Flats 

Neutron Dose Reconstruction Project 

Data in Dose Reconstructions’’), ORAU 

OTIB 0060 (‘‘Internal Dose 

Reconstructions’’), Program Evaluation 

Report (PER) 003 (‘‘The Effects of 

Adding Ingestion Intakes to Bethlehem 

Steel Cases’’), PER 004 (‘‘Application of 

Photofluorography at the Pinellas 

Plant’’), PER 005 (‘‘Misinterpreted 

Application of External Dose Factor for 

Hanford Dose Reconstructions’’), PER 

029 (‘‘Hanford TBD Revision’’), PER 042 

(‘‘Linde Ceramic Plant TBD Revision’’), 

PER 045 (‘‘Aliquippa Forge TBD 

Revision’’), ORAU PROC 0042 

(‘‘Incomplete Monitoring at Y–12’’), 

ORAU RPRT 0044 (‘‘Analysis of 

Bioassay Data with Significant Fraction 

of Less-Than Results’’); and a 

continuation of the comment-resolution 

process for other dose reconstruction 

procedures under review by the 

Subcommittee. 

The agenda is subject to change as 

priorities dictate. 

FOR FURTHER INFORMATION CONTACT: 

Theodore Katz, Designated Federal 

Officer, NIOSH, CDC, 1600 Clifton Road 

NE., Mailstop E–20, Atlanta, Georgia 

30333, Telephone (513) 533–6800, Toll 

Free 1(800) CDC–INFO, Email ocas@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2016–02081 Filed 2–3–16; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Request for Nominations of 

Candidates To Serve on the 

Interagency Committee on Smoking 

and Health, Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS) 

The CDC is soliciting nominations for 

possible membership on the Interagency 

Committee on Smoking and Health 

(ICSH), Office on Smoking and Health 

(OSH). 

The ICSH consists of five members 

appointed by the Secretary from 

physicians and scientists who represent 

private entities involved in informing 

the public about the health effects of 

smoking. The members are selected by 

the Secretary, HHS. The committee 

provides advice and guidance to the 

Secretary, HHS, and the Director, CDC 

regarding (a) coordination of all research 

and education programs and other 

activities within the Department and 

with other Federal, State, local and 

private agencies and (b) establishment 

and maintenance of liaison with 

appropriate private entities, Federal 

agencies, and State and local public 

health agencies with respect to smoking 

and health activities. 

Nominations are being sought for 

individuals who have expertise and 

qualifications necessary to contribute to 

the accomplishment of the committee’s 

objectives. More information is available 

on the ICSH, OSH Web site: http://

www.cdc.gov/tobacco/ICSH/index.htm. 

Nominees will be selected based on 

expertise in the field of tobacco control 

and multi-disciplinary expertise in 

public health. Additionally, desirable 

qualifications include: (1) Knowledge of 

emerging tobacco control policies and 

experience in analyzing, evaluating, and 

interpreting Federal, State and/or local 

health or regulatory policy; or (2) 

knowledge of emerging tobacco 

products and the evolving environment 

of tobacco control and expertise in 

developing or contributing to the 

development of policies and/or 

programs; or (3) familiarity of rapid and 

emerging surveillance systems that will 

allow for the timely evaluation of 

tobacco product regulation and/or the 

impact of tobacco control interventions. 

Federal employees will not be 

considered for membership. 

Members may be invited to serve for 

terms of up to four years. The U.S. 

Department of Health and Human 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 81, No. 23 / Thursday, February 4, 2016 / Notices 6009 

Services policy stipulates that 

committee membership shall be 

balanced in terms of professional 

training and background, points of view 

represented, and the committee’s 

function. In addition to a broad range of 

expertise, consideration is given to a 

broad representation of geographic areas 

within the U.S., with diverse 

representation of both genders, ethnic 

and racial minorities, and persons with 

disabilities. Nominees must be U.S. 

citizens, and cannot be full-time 

employees of the U.S. Government. 

Candidates should submit the 

following items: 

• Current curriculum vitae, including 

complete contact information (name, 

affiliation, mailing address, telephone 

number, email address). 

• A letter of recommendation from 

person(s) not employed by the U.S. 

Department of Health and Human 

Services. 

• A statement indicating the 

nominee’s willingness to potentially 

serve as a member of the Committee. 

Nominations should be submitted 

electronically or in writing, and must be 

postmarked by February 19, 2016 and 

sent to: Ms. Monica Swann, NCCDPHP, 

CDC, 395 E. Street SW., Room 9167, MS 

P06, Washington, DC 20024. (Email 

address: zqe0@cdc.gov). Telephone and 

facsimile submissions cannot be 

accepted. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2016–02082 Filed 2–3–16; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–9094–N] 

Medicare and Medicaid Programs; 

Quarterly Listing of Program 

Issuances—October Through 

December 2015 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice. 

SUMMARY: This quarterly notice lists 

CMS manual instructions, substantive 

and interpretive regulations, and other 

Federal Register notices that were 

published from July through September 

2015, relating to the Medicare and 

Medicaid programs and other programs 

administered by CMS. 

FOR FURTHER INFORMATION CONTACT: It is 

possible that an interested party may 

need specific information and not be 

able to determine from the listed 

information whether the issuance or 

regulation would fulfill that need. 

Consequently, we are providing contact 

persons to answer general questions 

concerning each of the addenda 

published in this notice. 

I. Background 

The Centers for Medicare & Medicaid 

Services (CMS) is responsible for 

administering the Medicare and 

Medicaid programs and coordination 

and oversight of private health 

insurance. Administration and oversight 

of these programs involves the 

following: (1) Furnishing information to 

Medicare and Medicaid beneficiaries, 

health care providers, and the public; 

and (2) maintaining effective 

communications with CMS regional 

offices, state governments, state 

Medicaid agencies, state survey 

agencies, various providers of health 

care, all Medicare contractors that 

process claims and pay bills, National 

Association of Insurance Commissioners 

(NAIC), health insurers, and other 

stakeholders. To implement the various 

statutes on which the programs are 

based, we issue regulations under the 

authority granted to the Secretary of the 

Department of Health and Human 

Services under sections 1102, 1871, 

1902, and related provisions of the 

Social Security Act (the Act) and Public 

Health Service Act. We also issue 

various manuals, memoranda, and 

statements necessary to administer and 

oversee the programs efficiently. 

Section 1871(c) of the Act requires 

that we publish a list of all Medicare 

manual instructions, interpretive rules, 

statements of policy, and guidelines of 

general applicability not issued as 

regulations at least every 3 months in 

the Federal Register. 


asabaliauskas on DSK5VPTVN1PROD with NOTICESEN04FE16.020</GPH>